文章引用情况
1
Multiple comparisons in non-inferiority trials: Reaction to recent regulatory guidance on multiple endpoints in clinical trials2
Design, data monitoring, and analysis of clinical trials with co-primary endpoints: A review3
Adaptive clinical endpoint bioequivalence studies with sample size re-estimation based on a nuisance parameter4
Influence Analysis for the Area Under the Receiver Operating Characteristic Curve5
Sample size determination for the current strategy in oncology Phase 3 trials that tests progression-free survival and overall survival in a two-stage design framework6
Randomization-based analysis of covariance for inference in the sequential parallel comparison design7
Combination of the weighted kappa coefficients of two binary diagnostic tests8
Evaluation of Alzheimer's disease progression based on clinical dementia rating scale with missing responses and covariates9
Curtailed two-stage design for comparing two arms in randomized phase II clinical trials10
Interchangeability Of Biological Drug Products-FDA Draft Guidance